Literature DB >> 27475536

Zinc-mediated binding of a low-molecular-weight stabilizer of the host anti-viral factor apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G.

Mohamed O Radwan1, Sachiko Sonoda1, Tomohiko Ejima1, Ayumi Tanaka1, Ryoko Koga1, Yoshinari Okamoto1, Mikako Fujita2, Masami Otsuka3.   

Abstract

Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G (APOBEC3G, A3G), is a human anti-virus restriction protein which works deaminase-dependently and -independently. A3G is known to be ubiquitinated by HIV-1 viral infectivity factor (Vif) protein, leading to proteasomal degradation. A3G contains two zinc ions at the N-terminal domain and the C-terminal domain. Four lysine residues, K(297), K(301), K(303), and K(334), are known to be required for Vif-mediated A3G ubiquitination and degradation. Previously, we reported compound SN-1, a zinc chelator that increases steady-state expression level of A3G in the presence of Vif. In this study, we prepared Biotin-SN-1, a biotinylated derivative of SN-1, to study the SN-1-A3G interaction. A pull-down assay revealed that Biotin-SN-1 bound A3G. A zinc-abstraction experiment indicated that SN-1 binds to the zinc site of A3G. We carried out a SN-1-A3G docking study using molecular operating environment. The calculations revealed that SN-1 binds to the C-terminal domain through Zn(2+), H(216), P(247), C(288), and Y(315). Notably, SN-1-binding covers the H(257), E(259), C(288), and C(291) residues that participate in zinc-mediated deamination, and the ubiquitination regions of A3G. The binding of SN-1 presumably perturbs the secondary structure between C(288) and Y(315), leading to less efficient ubiquitination.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  APOBEC3G; Biotin–avidin technology; HIV; Host anti-viral factor; Molecular docking; Zinc

Mesh:

Substances:

Year:  2016        PMID: 27475536     DOI: 10.1016/j.bmc.2016.07.030

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  9 in total

1.  Effects of Glycyrrhetic Acid on Human Chronic Myelogenous Leukemia Cells.

Authors:  Halilibrahim Çiftçi
Journal:  Turk J Pharm Sci       Date:  2020-02-19

2.  Marine Inspired 2-(5-Halo-1H-indol-3-yl)-N,N-dimethylethanamines as Modulators of Serotonin Receptors: An Example Illustrating the Power of Bromine as Part of the Uniquely Marine Chemical Space.

Authors:  Mohamed A Ibrahim; Abir T El-Alfy; Kelly Ezel; Mohamed O Radwan; Abbas G Shilabin; Anna J Kochanowska-Karamyan; Howaida I Abd-Alla; Masami Otsuka; Mark T Hamann
Journal:  Mar Drugs       Date:  2017-08-09       Impact factor: 5.118

3.  Experimental, molecular docking investigations and bioavailability study on the inclusion complexes of finasteride and cyclodextrins.

Authors:  Fatma M Mady; Usama Farghaly Aly
Journal:  Drug Des Devel Ther       Date:  2017-06-07       Impact factor: 4.162

4.  Design, Synthesis, and Biological Evaluation of Novel 1,3,4-Thiadiazole Derivatives as Potential Antitumor Agents against Chronic Myelogenous Leukemia: Striking Effect of Nitrothiazole Moiety.

Authors:  Mehlika Dilek Altıntop; Halil Ibrahim Ciftci; Mohamed O Radwan; Belgin Sever; Zafer Asım Kaplancıklı; Taha F S Ali; Ryoko Koga; Mikako Fujita; Masami Otsuka; Ahmet Özdemir
Journal:  Molecules       Date:  2017-12-27       Impact factor: 4.411

5.  The mechanism of bensulfuron-methyl complexation with β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin and effect on soil adsorption and bio-activity.

Authors:  Qianqian Geng; Tian Li; Xin Wang; Weijing Chu; Mengling Cai; Jingchan Xie; Hanwen Ni
Journal:  Sci Rep       Date:  2019-02-13       Impact factor: 4.379

6.  Antiproliferative S-Trityl-l-Cysteine -Derived Compounds as SIRT2 Inhibitors: Repurposing and Solubility Enhancement.

Authors:  Mohamed O Radwan; Halil I Ciftci; Taha F S Ali; Doha E Ellakwa; Ryoko Koga; Hiroshi Tateishi; Akiko Nakata; Akihiro Ito; Minoru Yoshida; Yoshinari Okamoto; Mikako Fujita; Masami Otsuka
Journal:  Molecules       Date:  2019-09-10       Impact factor: 4.411

7.  Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria.

Authors:  Shengfeng Wang; Jason J Pitt; Yonglan Zheng; Toshio F Yoshimatsu; Guimin Gao; Ayodele Sanni; Olayiwola Oluwasola; Mustapha Ajani; Dominic Fitzgerald; Abayomi Odetunde; Galina Khramtsova; Ian Hurley; Abiodun Popoola; Adeyinka Falusi; Temidayo Ogundiran; John Obafunwa; Oladosu Ojengbede; Nasiru Ibrahim; Jordi Barretina; Kevin P White; Dezheng Huo; Olufunmilayo I Olopade
Journal:  Int J Cancer       Date:  2019-06-27       Impact factor: 7.396

8.  Comparative study of β-cyclodextrin, γ-cyclodextrin and 4-tert-butylcalix[8]arene ionophores as electroactive materials for the construction of new sensors for trazodone based on host-guest recognition.

Authors:  Haitham Alrabiah; Haya I Aljohar; Ahmed Hassan Bakheit; Atef Ma Homoda; Gamal Abdel-Hafiz Mostafa
Journal:  Drug Des Devel Ther       Date:  2019-07-11       Impact factor: 4.162

9.  Blockade of TGF-β/Smad signaling by the small compound HPH-15 ameliorates experimental skin fibrosis.

Authors:  Vu Huy Luong; Takenao Chino; Noritaka Oyama; Takashi Matsushita; Yoko Sasaki; Dai Ogura; Shin-Ichiro Niwa; Tanima Biswas; Akiyuki Hamasaki; Mikako Fujita; Yoshinari Okamoto; Masami Otsuka; Hironobu Ihn; Minoru Hasegawa
Journal:  Arthritis Res Ther       Date:  2018-03-15       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.